Dr. Sukgu Han on target vessel patency after TAAA repair
Target vessel patency remains a critical challenge in endovascular thoracoabdominal aortic aneurysm (TAAA) repair.
In this exclusive interview recorded during Critical Issues 2026, Dr. Sukgu Han highlights the role of renal artery target vessel patency as a key limiting factor, raising important questions around optimisation strategies.
From antiplatelet regimens to evolving bridging stent configurations, early signals suggest new approaches may help improve outcomes.
What could make the difference in long-term success?
Hit play to explore the full perspective.
N.B.: Dr. Sukgu Han, also Course Director of ATLAS-PVI Aortic 2026, will share more insights during this practical, case-based international course in Los Angeles. Stay tuned for updates!
Get the latest clinical cases and breaking news delivered straight to your inbox!
